Announcement
07 Jun 2021
Pakistan has amended the duty drawback on the exports of certain pharmaceutical goods when they are manufactured with the use of certain imported raw materials. The list of imported raw materials covered has also been amended.
Source
Sign in to access
Number of interventions
4
2 certainly harmful
0 likely harmful
2 liberalising
List of interventions
Implementation date
07 Jun 2021
Revocation date:
No revocation date
Updated: 07 Jun 2021
Import tariff
In force
On 7 June 2021, Pakistan's Federal Board of Revenue through SRO 751(I)/2021 reduced the effective import tariff on the imports of certain products by increasing the duty drawback rates on tabl...
Sign in to see more
Updated: 07 Jun 2021
Tax-based export incentive
In force
On 7 June 2021, Pakistan's Federal Board of Revenue through SRO 751(I)/2021 reduced the maximum duty drawback on the exports of pharmaceutical suspensions from 1.15% to 0.30% of the ...
Sign in to see more
Implementation date
07 Jun 2021
Revocation date:
No revocation date
Updated: 07 Jun 2021
Import tariff
In force
On 7 June 2021, Pakistan's Federal Board of Revenue through SRO 751(I)/2021 amended the list of raw materials that could be imported and used to manufacture certain pharmaceutical goods for ex...
Sign in to see more
Updated: 07 Jun 2021
Tax-based export incentive
In force
On 7 June 2021, Pakistan's Federal Board of Revenue through SRO 751(I)/2021 increased the maximum duty drawback on the exports of tablets and capsules from 1.32% to 2.10% of the FOB value. The draw...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.